Is this you?
Request access for Chase Medical Research with your @chasemr.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Chase Medical Research
Unclaimed profileIndependent Site · Waterbury, Connecticut · ~2 sites
Intera lens
ICP 7Lift (cardio sample) 0.29Recruit soph 0.71
Quality Scorecard (1–100)
Overall91Recruit82Ops94Sponsor96Ther96
Performance (observed)
Historical trials
800
Completed
495
Terminated/Withdrawn
101
Completion rate
83%
Active now
176
Phase 2
318
Phase 3
399
Realized enrollment
636,030
First study year
1993
Years active
33
Match confidence
low
Enrollment velocity (inf)
19,274
Therapeutic
Areas
Endocrine (Type 2 Diabetes, DPN, NASH, Fatty Liver), Obesity, Cardiovascular, Nephrology, Vaccines, Devices, Pain Management
Specialties
Diabetes (T2, neuropathy), obesity/weight mgmt, cardiovascular (hyperlipidemia, hypertension), liver disease (NAFLD/NASH), CKD/anemia, migraines, osteoarthritis, GI (GERD, IBS), respiratory, pain, overactive bladder, devices
Breadth (conditions)
1,223
States
Connecticut
Recruitment (web observed)
Meta Pixel
Yes
Facebook Ads
Yes
Trial Finder
Yes
Patient database
Y (750,000+ potential subjects in catchment)
Advertises recruitment
Yes
SEO
Active website with capabilities/facility info
Capability notes
High - 750,000+ catchment area, 16,050 sq ft research space, 99% enrollment success on vaccine/healthy trials
Relationships
Sponsors
National Cancer Institute (NCI); Radiation Therapy Oncology Group; Eastern Cooperative Oncology Group; Gynecologic Oncology Group; Pfizer; Alliance for Clinical Trials in Oncology
CROs
Acrotech Biopharma Inc.; Fortrea; MacroGenics; Parexel; The Emmes Company, LLC
Partnerships
PhaseWell Research (acquired 2026)
Owner / parent
Unknown
Funding
PhaseWell Research (acquired March 2026)
Acquisitions
Acquired by PhaseWell Research (March 2026)
Expansion
Y - 2 Connecticut locations, 96% retention rate, 400+ trials
Recent hiring
Y - Clinical Research Coordinators (APRN/PA, RN/LPN, Assistants)
Capacity & people
Investigators
—
Coordinators
—
CEO
Joseph Soufer, MD
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Kate Schrack (Recruitment & Engagement Manager)
Emails
research@chasemr.com, 203-465-7924, 203-419-4404
Tech & DCT
eSource
Yes
eConsent
Yes
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Established 2000, 350+ trials conducted, 96% retention on long-term trials, multi-therapeutic focus. ClinicalTrials.gov validation: 5 active recruiting cardiometabolic trials. Strong recruitment capability and proven enrollment track record make this a good fit for Intera. No visible AI or DCT adoption.
Recommendation features (sample indication)
Ind fit 1.00Liftability 0.29Overall91
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.